RWD comprises various data gathered outside of traditional clinical research settings. This includes electronic health records (EHRs), insurance claims, patient registries and wearable device data.

Thanks to new regulatory frameworks like the Food and Drug Administration’s Breakthrough Therapy designation, drugs are coming to market faster than ever. A 2024 analysis of drugs included in this ...

In a world where connectivity and data reign supreme, the internet of things (IoT) has emerged as a groundbreaking technology that’s not just a buzzword, but a tangible reality with impressive ...

Healthcare systems worldwide are facing unprecedented pressure, from the rise in chronic diseases and aging populations to fragmented healthcare and over-stretched resources. The result? Delayed, ...

The rise in direct-to-patient therapeutics access via online compounding pharmacies and other direct-to-patient sales models has increased the likelihood of patients utilizing medications alongside ...

Mayo Clinic clinicians are starting to explore how they might use healthcare-specific large language models – accessed through a generative artificial intelligence chat application – to enhance ...

Randomized trials provide high-quality, internally consistent data on selected clinical questions, but lack generalizability for the aging population who are most often diagnosed with cancer and have ...

Jeffrey Stark, MD, vice president, head of medical immunology, UCB, discusses ongoing clinical trials and the development of real-world data to understand the effectiveness of bimekizumab-bkzx in a ...

Today’s health care leaders are awash in data. There’s no shortage of organizations collecting, structuring, and licensing massive real-world data sets, each touting millions of de-identified “patient ...